Trial Profile
A study to evaluate the efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 17 Nov 2015 New trial record